Smitha Menon

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization

Siraj M. Ali, Thomas A. Hensing, Alexa B. Schrock et al. · The Oncologist · 2016 · 115 citations · Full text

Medicine, Genetics, Oncology +17

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Thromboembolic events with lenalidomide‐based therapy for multiple myeloma

Smitha Menon, S. Vincent Rajkumar, Martha Q. Lacy et al. · Cancer · 2008 · 85 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC

Viola W. Zhu, Adam J. Schoenfeld, Beow Y. Yeap et al. · Journal of Thoracic Oncology · 2018 · 82 citations · Full text

Medicine, Oncology, Pharmacology +9